Antibiotics and Antibiotic Resistance: Mechanisms, Challenges, and Clinical Applications

Antimicrobials: Introduction and Importance

Definition and Role of Antimicrobials

Antimicrobials are agents that kill or inhibit the growth of microorganisms, including bacteria, viruses, fungi, and parasites. They are essential tools in modern medicine for treating infectious diseases and preventing the spread of pathogens.

• Antibiotics are a subset of antimicrobials that specifically target bacteria.

• Antimicrobials can be natural, semi-synthetic, or synthetic compounds.

• They are needed to control infections, reduce morbidity and mortality, and enable medical procedures that would otherwise be too risky due to infection.

Example: Penicillin, the first widely used antibiotic, revolutionized the treatment of bacterial infections.

Features of Effective Antimicrobial Drugs

Characteristics and Targets

Good antimicrobial drugs possess several key features to ensure efficacy and safety.

• Selectivity: Should target microbial structures or processes not found in host cells (e.g., bacterial cell wall).

• Low toxicity: Minimal adverse effects on the host.

• Broad or narrow spectrum: Depending on the infection, drugs may target a wide range of organisms (broad-spectrum) or specific pathogens (narrow-spectrum).

• Minimal resistance development: Should not easily select for resistant strains.

Example: Beta-lactam antibiotics target peptidoglycan synthesis, a process unique to bacteria.

Consequences of Antibiotic Use

Impact on Microbiota and Resistance

Antibiotic use can have unintended consequences, including disruption of normal microbiota and selection for resistant pathogens.

• Normal microbiota suppresses opportunistic pathogens.

• Broad-spectrum antibiotics may kill beneficial microbes, allowing drug-resistant pathogens to proliferate and cause superinfections.

Example: Clostridioides difficile infection often follows broad-spectrum antibiotic therapy.

Antibiotic Administration

Routes and Pharmacokinetics

The route of antibiotic administration affects drug concentration and efficacy.

• Oral: Convenient, slower peak concentration.

• Intramuscular (IM): Faster absorption than oral, moderate peak.

• Intravenous (IV): Rapid peak concentration, used for severe infections.

Pharmacokinetic equation:

$C(t) = C_0 e^{-kt}$

where $C(t)$ is the concentration at time $t$, $C_0$ is the initial concentration, and $k$ is the elimination rate constant.

Societal Factors Affecting Antibiotic Use

Patient Pressure and Public Perceptions

Patient expectations and misconceptions influence prescribing practices and antibiotic misuse.

• Patients may request antibiotics for viral infections, where they are ineffective.

• Surveys show many people believe antibiotics work against viruses, which is incorrect.

Perception	General Public 2010	General Public 2019
Only on bacteria	40%	50%
Both viruses and bacteria	14%	22%
Only on viruses	14%	11%
You don't know	17%	32%

Additional info: Misuse contributes to resistance and reduced drug efficacy.

Spectrum of Antimicrobials

Range of Activity

Antimicrobials vary in their spectrum, targeting different groups of microorganisms.

• Broad-spectrum: Active against a wide range of bacteria (e.g., tetracyclines).

• Narrow-spectrum: Target specific bacteria (e.g., penicillin for Gram-positive bacteria).

• Some drugs target fungi (e.g., azoles), viruses (e.g., nucleoside analogs), or parasites.

Microbe Type	Example Drugs
Gram-positive bacteria	Penicillins, Vancomycin
Gram-negative bacteria	Aminoglycosides, Quinolones
Fungi	Azoles, Polyenes
Viruses	Fusion inhibitors, Nucleoside analogs

Potential Targets of Antimicrobials

Cellular Structures and Processes

Antimicrobials act by interfering with essential microbial functions.

• Cell wall synthesis: Beta-lactams, glycopeptides

• Protein synthesis: Aminoglycosides, tetracyclines, macrolides

• DNA replication: Quinolones (target DNA gyrase)

• RNA synthesis: Rifampin, actinomycin

• Metabolic pathways: Sulfa drugs, trimethoprim

• Membrane structure: Polymyxins, daptomycin

Cell Wall Synthesis Inhibitors

Beta-lactams

Beta-lactam antibiotics are among the most widely used and act by inhibiting peptidoglycan cross-linking in bacterial cell walls.

• Include penicillins, cephalosporins, carbapenems, and monobactams.

• Mechanism: Bind to penicillin-binding proteins (PBPs), blocking transpeptidation.

Chemical structure:

$\text{Beta-lactam ring:} \quad \ce{C4H5NO}$

Example: Penicillin G is effective against Gram-positive bacteria but is acid-sensitive and susceptible to beta-lactamase.

Penicillin Type	Properties
Methicillin	Acid-stable, beta-lactamase-resistant
Oxacillin	Acid-stable, beta-lactamase-resistant
Ampicillin	Broadened spectrum, acid-stable
Carbenicillin	Broadened spectrum, acid-stable, beta-lactamase-sensitive

Cephalosporins

Cephalosporins share the beta-lactam ring structure and mechanism but are more resistant to beta-lactamases.

• Effective against a broader range of bacteria.

• Example: Ceftriaxone is used for severe infections.

Non-beta-lactam Cell Wall Inhibitors

Other drugs inhibit cell wall synthesis by different mechanisms.

• Vancomycin: Binds D-Ala-D-Ala termini, blocking transpeptidation.

• Bacitracin: Inhibits lipid carrier recycling.

• Daptomycin: Causes membrane depolarization.

Growth Factor Analogs

Mechanism and Examples

Growth factor analogs mimic essential metabolites but disrupt normal cellular function.

• Sulfa drugs: Mimic para-aminobenzoic acid (PABA), inhibiting folic acid synthesis.

• Trimethoprim: Inhibits dihydrofolate reductase, blocking folic acid pathway.

Resistance: Bacteria may acquire the ability to uptake folic acid from the environment, bypassing the blocked pathway.

Solution: Combination therapy with sulfa drugs and trimethoprim increases efficacy.

Antibiotics Targeting Protein Synthesis

Major Classes and Mechanisms

These antibiotics inhibit bacterial ribosomes, preventing protein production.

• Chloramphenicol, macrolides, lincosamides: Bind 50S subunit, inhibit peptide bond formation.

• Aminoglycosides: Bind 30S subunit, cause misreading of mRNA.

• Tetracyclines: Bind 30S subunit, block tRNA attachment.

Antibiotics Targeting DNA Gyrase

Quinolones

Quinolones, such as ciprofloxacin and moxifloxacin, inhibit DNA gyrase, an enzyme essential for DNA replication and supercoiling.

• Disruption of DNA gyrase prevents bacterial cell division and leads to cell death.

Antibiotics Targeting Nucleic Acid Synthesis

RNA Synthesis Inhibitors

These drugs block transcription by interfering with RNA polymerase or DNA template.

• Rifampin: Binds bacterial RNA polymerase, blocks initiation.

• Actinomycin: Binds DNA, prevents RNA polymerase elongation.

Additional info: Bacterial and eukaryotic RNA polymerases are structurally similar, but eukaryotic enzymes are more complex.

Antimicrobial Resistance

Key Concepts and Mechanisms

Resistance arises when microbes survive exposure to antimicrobials and proliferate.

• Resistance is pre-existing in populations and is selected for by antibiotic use.

• Most resistance genes are carried on plasmids or other mobile genetic elements.

Mechanisms of Resistance

• Efflux pumps: Remove drug from cell (e.g., tetracyclines, macrolides).

• Blocked penetration: Prevent drug entry (e.g., penicillins, fluoroquinolones).

• Inactivation of enzymes: Destroy or modify drug (e.g., beta-lactamases).

• Target modification: Alter drug target (e.g., ribosomal mutations).

Antiviral Drugs

Challenges and Targets

Designing antiviral drugs is difficult due to the reliance of viruses on host cell machinery, making selective toxicity challenging.

• Targets include viral entry, nucleic acid synthesis, protease activity, and specific viral enzymes.

Target	Example Drug
Fusion to host cell	Enfuvirtide (HIV)
DNA/RNA synthesis	Acyclovir (HSV), AZT (HIV)
Protease activity	Saquinavir (HIV)
Neuraminidase	Tamiflu (Influenza)

Example: Tamiflu inhibits neuraminidase, preventing release of influenza virus from host cells.

Antifungal Drugs

Challenges in Treating Fungal Infections

Fungal infections are increasingly common in immunocompromised individuals. Treatment is difficult because fungi are eukaryotes and share many cellular features with human cells.

• Few unique targets; drugs may be toxic to host.

• Common targets: ergosterol synthesis (e.g., azoles, polyenes).

Additional info: Human cells contain cholesterol, while fungal cells contain ergosterol, providing a selective target.

Staphylococcus aureus and Antibiotic Resistance

Virulence and Resistance Trends

Staphylococcus aureus is a major pathogen with increasing antibiotic resistance, including MRSA (methicillin-resistant S. aureus) and VRSA (vancomycin-resistant S. aureus).

• Resistance has increased since the introduction of penicillin and methicillin.

• Virulence factors include toxins, enzymes, and immune evasion mechanisms.

Example: MRSA is a significant cause of hospital- and community-acquired infections.

Discovery and Development of New Antimicrobials

Challenges and Strategies

Despite the need for new antibiotics, few are clinically useful due to toxicity, poor pharmacokinetics, or rapid resistance development.

• Recent decades have seen a decline in new drug approvals.

• Strategies include computer modeling, screening uncultured microbes, and combination therapies.

Decade	New Antimicrobials Approved
1983-1987	16
2008-2012	2

Example: Platensimycin, a lipid biosynthesis inhibitor, was discovered from soil bacteria.

• Combination therapy: Using multiple drugs to prevent resistance (e.g., beta-lactam + beta-lactamase inhibitor, ART for HIV).

Additional info: Computer modeling helps design drugs targeting specific microbial proteins.